Morgan Stanley Reiterates Overweight Rating on Huntington Bancshares (HBAN), Moves to Top Pick

Morgan Stanley analyst Manan Gosalia reiterated an Overweight rating and $21.00 price target on Huntington Bancshares (NASDAQ: HBAN)

The analyst comments: "The HBAN shares have underperformed peers on higher uncertainty around achieving its $2 EPS guidance for 2027. HBAN is down by 2% since the company reported earnings on January 22, making it one of the worst performing stocks in the group during the span. This underperformance follows the company's higher-than- expected 2026 expense guidance, which has introduced higher uncertainty to achieving the $2 EPS guidance it set for 2027.

Huntington's organic earnings growth flywheel was on full display in 2025 with mid-teens PPNR growth driven by high-single-digit organic loan growth and 290bps of positive operating leverage, all while investing to add new revenue producing capabilities to the franchise. Integrating 3 deals at once (VBTX, CADE, Janney Capital Markets) while simultaneously investing more in these newly acquired markets is adding significant noise to 2026 numbers. Market is missing that the benefits of the acquisitions along with stronger core growth come through in 2027."

For an analyst ratings summary and ratings history on Huntington Bancshares click here. For more ratings news on Huntington Bancshares click here.

Shares of Huntington Bancshares closed at $18.39 yesterday.

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• Genco Shipping urges shareholders to reject Diana's $24.80 takeover bid
• After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,